.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
US Department of Justice
Boehringer Ingelheim
Teva
Fuji
Argus Health
Mallinckrodt
Deloitte
Citi
Cantor Fitzgerald

Generated: November 21, 2017

DrugPatentWatch Database Preview

Epinastine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for epinastine hydrochloride and what is the scope of epinastine hydrochloride patent protection?

Epinastine hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex, Sun Pharm Inds, Somerset Theraps Llc, Akorn, Allergan, Breckenridge Pharm, and Sandoz Inc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for epinastine hydrochloride. Six suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for epinastine hydrochloride

Tentative approvals for EPINASTINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
u► Subscribe0.05%SOLUTION; OPHTHALMIC
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC203384-001Dec 7, 2016ATRXNoNo► Subscribe► Subscribe► Subscribe
Apotex
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090919-001Oct 31, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Allergan
ELESTAT
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC021565-001Oct 16, 2003ATRXYesYes► Subscribe► Subscribe► Subscribe
Somerset Theraps Llc
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090951-001Oct 31, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Akorn
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC204055-001May 5, 2017ATRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090870-001Mar 14, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
EPINASTINE HYDROCHLORIDE
epinastine hydrochloride
SOLUTION/DROPS;OPHTHALMIC091626-001Oct 31, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
UBS
Deloitte
QuintilesIMS
Teva
Novartis
Express Scripts
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot